Bellerophon Therapeutics, Inc. financial data

Location
184 Liberty Corner Road, Suite 302, Warren, NJ
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2023 - Nov 14, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Debt-to-equity 78.5 % +110%
Return On Equity -165 % -24%
Return On Assets -92.2 % +4.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 12.2M shares +28.2%
Common Stock, Shares, Outstanding 12.2M shares +28.2%
Common Stock, Value, Issued 122K USD +28.4%
Weighted Average Number of Shares Outstanding, Basic 12.2M shares +28.2%
Weighted Average Number of Shares Outstanding, Diluted 12.2M shares +28.2%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 6.97M USD +20.9%
Operating Income (Loss) -11M USD +48.8%
Nonoperating Income (Expense) 109K USD +132%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -10.5M USD +51%
Income Tax Expense (Benefit) -1.28M USD
Net Income (Loss) Attributable to Parent -9.25M USD +51.5%
Earnings Per Share, Basic -1 USD/shares +57.8%
Earnings Per Share, Diluted -1 USD/shares +57.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.38M USD -61.3%
Assets, Current 4.98M USD -58.7%
Operating Lease, Right-of-Use Asset 0 USD -100%
Other Assets, Noncurrent 0 USD -100%
Assets 4.98M USD -60.5%
Liabilities, Current 1.26M USD -75.7%
Liabilities 1.26M USD -75.8%
Retained Earnings (Accumulated Deficit) -256M USD -3.75%
Stockholders' Equity Attributable to Parent 3.72M USD -49.9%
Liabilities and Equity 4.98M USD -60.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 3.27M USD
Net Cash Provided by (Used in) Financing Activities 4.98M USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 12.2M shares +28.2%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 8.25M USD
Operating Lease, Liability 0 USD -100%
Operating Lease, Liability, Current 8K USD -99%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Operating Lease, Payments 599K USD -22.8%
Additional Paid in Capital 260M USD +2.17%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 580K USD -19.9%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%